EPS (Diluted) for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current diluted EPS (TTM) is $3.45. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$3.45
YoY change
-178.2%
5Y CAGR
N/A
Peak year (2009)
$5.37
Latest annual
$3.45
EPS (Diluted) history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
EPS (Diluted) history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $3.45 | -178.2% | ||
| 2024 | $-4.41 | -214.2% | ||
| 2023 | $3.86 | +30.8% | ||
| 2022 | $2.95 | -5.4% | ||
| 2021 | $3.12 | -178.4% | ||
| 2020 | $-3.98 | -298.0% | ||
| 2019 | $2.01 | -33.7% | ||
| 2018 | $3.03 | +396.7% | ||
| 2017 | $0.61 | -77.0% | ||
| 2016 | $2.65 | +173.2% | ||
| 2015 | $0.97 | -19.2% | ||
| 2014 | $1.20 | -22.1% | ||
| 2013 | $1.54 | +32.8% | ||
| 2012 | $1.16 | -46.3% | ||
| 2011 | $2.16 | +20.0% | ||
| 2010 | $1.80 | -66.5% | ||
| 2009 | $5.37 | +105.0% | ||
| 2008 | $2.62 | +140.4% | ||
| 2007 | $1.09 | +34.6% | ||
| 2006 | $0.81 | -46.4% | ||
| 2005 | $1.51 | +24.8% | ||
| 2004 | $1.21 | -23.9% | ||
| 2003 | $1.59 | +55.9% | ||
| 2002 | $1.02 | -61.8% | ||
| 2001 | $2.67 | +13.1% | ||
| 2000 | $2.36 | +14.6% | ||
| 1999 | $2.06 | +32.9% | ||
| 1998 | $1.55 | -1.3% | ||
| 1997 | $1.57 | +12.1% | ||
| 1996 | $1.40 | +57.3% | ||
| 1995 | $0.89 | -1.1% | ||
| 1994 | $0.90 | -5.3% | ||
| 1993 | $0.95 | -1.0% | ||
| 1992 | $0.96 | -3.0% | ||
| 1991 | $0.99 | +17.9% | ||
| 1990 | $0.84 | +133.3% | ||
| 1989 | $0.36 | -40.0% | ||
| 1988 | $0.60 | +20.0% | ||
| 1987 | $0.50 | — |
EPS (Diluted) values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bristol-Myers Squibb (BMY) most recent annual diluted EPS stands at $3.45 (2025) – plunged 178.2% year-over-year.
Through 2015–2025 (10 years), Bristol-Myers Squibb diluted EPS delivered a +13.5% annualised rate; with the latest reading among the more recent periods of the dataset.
Bristol-Myers Squibb diluted EPS peaked at $5.37 in 2009; the latest annual figure is $3.45 in 2025 (35.8% below peak).
Across the available history, diluted EPS reached its high of $5.37 in 2009 and its low of $-4.41 in 2024.
Among 8 Healthcare peers, Bristol-Myers Squibb (BMY) ranks 8th; the peer median for diluted EPS is $13.16.
Bristol-Myers Squibb EPS (Diluted) by Year
Bristol-Myers Squibb EPS (Diluted) 2025: $3.45
Bristol-Myers Squibb diluted EPS in 2025 was $3.45, plunged 178.2% below 2024.
Bristol-Myers Squibb EPS (Diluted) 2024: $-4.41
Bristol-Myers Squibb diluted EPS in 2024 was $-4.41, plunged 214.2% below 2023. This figure represents the lowest annual value in the available history.
Bristol-Myers Squibb EPS (Diluted) 2023: $3.86
Bristol-Myers Squibb diluted EPS in 2023 was $3.86, surged 30.8% from 2022.
Bristol-Myers Squibb EPS (Diluted) 2022: $2.95
Bristol-Myers Squibb diluted EPS in 2022 was $2.95, declined 5.4% below 2021.
Bristol-Myers Squibb EPS (Diluted) 2021: $3.12
Bristol-Myers Squibb diluted EPS in 2021 was $3.12.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — EPS (Diluted)
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's diluted EPS?
- Latest reported diluted EPS for Bristol-Myers Squibb (BMY) is $3.45 (period ending December 31, 2025).
How has Bristol-Myers Squibb diluted EPS changed year-over-year?
- Bristol-Myers Squibb (BMY) diluted EPS changed -178.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb diluted EPS?
- Bristol-Myers Squibb (BMY) diluted EPS compound annual growth rate is +13.5% over the most recent 10 years available.
When did Bristol-Myers Squibb diluted EPS hit its highest annual value?
- Bristol-Myers Squibb diluted EPS reached its highest annual value of $5.37 in 2009.
What was Bristol-Myers Squibb diluted EPS in 2024?
- Bristol-Myers Squibb (BMY) diluted EPS in 2024 was $-4.41.
What was Bristol-Myers Squibb diluted EPS in 2025?
- Bristol-Myers Squibb (BMY) diluted EPS in 2025 was $3.45.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.